Asthma

Join Clinical Trials for Asthma

In General

Asthma makes breathing difficult for millions of Americans, and its incidence is on the rise in both adults and children. Although the coughing, wheezing, and chest tightness associated with asthma attacks can be frustrating to deal with and at times, difficult to manage, it is important to not lose hope and to maintain a positive outlook.

Research related to asthma offers promising signs of improved therapies, management strategies, and an overall better understanding of the nature of asthma in the coming years.

Currently, considerable research is being conducted on asthma from a number of perspectives.

Some research is working to better identify the environmental factors that trigger asthma symptoms, as well as the genetic characteristics that cause people to be more susceptible to those triggers.

In addition, research is being conducted to test newer methods of treating asthma symptoms, and ways of preventing or delaying their onset. 

Continued … Asthma Clinical Trials (Click to Open)

Join Clinical Trials for Asthma

What do Typical Clinical Trials for Asthma involve?

When participating in a clinical trial designed to investigate some aspect related to Clinical trials for asthmaasthma, there are a few basic tests and procedures you may receive; however, the ultimate design of the particular study will determine which specific procedures you will undergo.

On a basic level, however, you can expect any one or combination of the following: allergy testing; lung exam with a stethoscope; blood tests to check for oxygen and other gas levels; blood tests to check for immune system cells; chest x-rays; and lung function tests (which measure how well your lungs take in an release air, as well as how efficiently they move oxygen into and out of your blood).

Examples of Clinical Trials for Asthma

Currently, research related to asthma covers a broad range of topics. Specific examples might include the following:

  • The impact of urban versus rural living on the development of food allergies in children.
  • The effects of maternal smoking during pregnancy on rates of asthma in children and teenagers.
  • The association between the immune system and the development of asthma
  • Characteristics of the immune system that may lead to the development of more effective allergy medications.
  • Head-to-head comparison of an established asthma treatment with a new, investigational drug delivered through an inhaler during a severe asthma attack.

Suggested Search Terms:

 “asthma children,” “severe asthma,” “asthma control,” “asthma exacerbation,” “asthma triggers,” “asthma smoking,” “asthma acute,” “asthma occupation,” and “asthma management.”

Current Search Term: “Asthma”



The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma


Condition:   Asthma
Interventions:   Drug: Fluticasone Furoate/Vilanterol;   Drug: Fluticasone Furoate;   Drug: Salbutamol/Albuterol
Sponsors:   GlaxoSmithKline;   Parexel
Not yet recruiting


Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma


Condition:   Asthma
Interventions:   Biological: Experimental: Tezepelumab;   Other: Placebo
Sponsors:   AstraZeneca;   Amgen
Recruiting


Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma


Condition:   Asthma
Interventions:   Drug: CJM112;   Other: Placebo to CJM112
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting


Pilot of Lifestyle and Asthma Intervention


Condition:   Asthma
Intervention:   Behavioral: Weight loss intervention
Sponsors:   Johns Hopkins University;   American Lung Association;   National Heart, Lung, and Blood Institute (NHLBI);   University of Vermont;   University of Arizona
Recruiting


To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled Corticosteroids


Condition:   Asthma
Interventions:   Drug: Abediterol;   Drug: Placebo
Sponsor:   AstraZeneca
Completed


Asthma Mobile Health Application 2.0


Condition:   Asthma
Interventions:   Other: Current Daily Survey;   Other: Mobile Health App
Sponsors:   Icahn School of Medicine at Mount Sinai;   Apple Inc.;   Lifemap Solutions, Inc;   Sage Bionetworks
Completed


Pulmonary Rehabilitation in Asthma Control


Condition:   Asthma
Intervention:   Other: Exercise
Sponsor:   Izmir Katip Celebi University
Completed



Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma


Condition:   Asthma
Interventions:   Drug: QAW039;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting


The Electronic Asthma Management System


Condition:   Asthma
Intervention:   Other: Electronic Asthma Management System: eAMS
Sponsors:   St. Michael's Hospital, Toronto;   Ontario Lung Association
Not yet recruiting


Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment


Condition:   Asthma
Interventions:   Drug: QAW039 Dose 1;   Drug: QAW039 Dose 2;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Recruiting


Disclosure of Smoking in Adolescents With Asthma


Condition:   Asthma
Interventions:   Other: Group 1 - Parents will be present for the Questionnaire.;   Other: Group 2- Parents will not be present for the Questionnaire
Sponsors:   Imperial College London;   The Whittington Hospital NHS Trust
Recruiting


Errors in the Use of Turbuhaler and Spiromax Devices Patients With Asthma


Condition:   Asthma
Interventions:   Device: TURBUHALER®;   Device: SPIROMAX®
Sponsor:   Fundación Pública Andaluza Progreso y Salud
Recruiting


Imperial County Asthma CER Project: Respira Sano


Condition:   Asthma
Intervention:   Behavioral: Respira Sano
Sponsors:   San Diego State University;   Patient-Centered Outcomes Research Institute
Active, not recruiting


Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Asthma


Condition:   Asthma
Interventions:   Device: CREON2000A;   Device: Sham
Sponsors:   General Innovations and Goods, Inc.;   National Institute of Allergy and Infectious Diseases (NIAID);   University of Cincinnati;   Bernstein Clinical Research Center
Recruiting


Asthma and Pest Control Study: Demonstrating Return-on-Investment for In-Home Pest Control for Children With Persistent Asthma


Condition:   Asthma
Intervention:   Other: Integrated Pest Management
Sponsors:   New York City Department of Health and Mental Hygiene;   Montefiore Medical Center;   Healthfirst;   Affinity Health Plan
Active, not recruiting


Vitamin D to Prevent Severe Asthma Exacerbations (Vit-D-Kids Asthma)


Condition:   Asthma
Interventions:   Drug: vitamin D3 4000 IU;   Drug: Placebo
Sponsors:   Juan Celedon, MD;   Pharmavite;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting


Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma


Condition:   Asthma
Interventions:   Drug: QVM149;   Drug: QMF149;   Drug: salmeterol/fluticasone
Sponsor:   Novartis Pharmaceuticals
Recruiting


A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma


Condition:   Asthma
Intervention:   Drug: MEDI9929, 140 mg
Sponsors:   MedImmune LLC;   Amgen
Completed


Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma


Condition:   Asthma
Interventions:   Drug: QGE031;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Terminated


Randomized Prospective Trial of a Mobile Health Application for Asthma Self-Management


Condition:   Asthma
Interventions:   Other: AsthmaCare mobile health application;   Other: Asthma education
Sponsor:   David Stukus
Enrolling by invitation


Home Centered Comprehensive Care (HCCC) for Children With Asthma


Condition:   Asthma
Interventions:   Other: Standard comprehensive care;   Other: enhanced comprehensive care
Sponsors:   The University of Texas Health Science Center, Houston;   Centers for Medicare and Medicaid Services;   National Institutes of Health (NIH)
Completed


The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China


Condition:   Asthma
Intervention:  
Sponsor:   AstraZeneca
Completed


Triple in Asthma Dose Finding


Condition:   Asthma
Interventions:   Drug: CHF 5259 plus Foster 100/6 µg;   Drug: Foster 100/6 µg
Sponsor:   Chiesi Farmaceutici S.p.A.
Completed


Washington University Severe Asthma Research Program III


Condition:   Asthma
Intervention:  
Sponsor:   Washington University School of Medicine
Active, not recruiting

Refine Your Search Advanced Search